SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS |
SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS
|
|
Employee Stock |
|
|
|
Option
Granted |
|
|
|
2021 |
|
Weighted-average fair value per share |
|
$ |
3.51 |
|
Risk -free interest rate (1) |
|
|
1.05 |
% |
Expected volatility of stock
(2) |
|
|
58.61 |
% |
Dividend yield |
|
|
None |
|
Expected option life (3) |
|
|
5.0
years |
|
|
|
Outside
Director Stock Options Granted |
|
|
|
2021 |
|
|
2020 |
|
Weighted-average fair value per share |
|
$ |
3.9 |
|
|
$ |
4.66 |
|
Risk -free interest rate (1) |
|
|
1.23%-1.61 |
% |
|
|
0.59%-1.61 |
% |
Expected volatility of stock
(2) |
|
|
55.84%-55.91 |
% |
|
|
55.83%-56.68 |
% |
Dividend yield |
|
|
None |
|
|
|
None |
|
Expected option life (3) |
|
|
10.0
years |
|
|
|
10.0
years |
|
(1) |
The risk-free interest rate is based on the U.S. Treasury yield
in effect at the grant date over the expected term of the option. |
(2) |
The expected volatility is based on historical volatility from
our traded Common Stock over the expected term of the option. |
(3) |
The expected option life is based on historical exercises and
post-vesting data. |
|
SCHEDULE OF SHARE-BASED COMPENSATION, ALLOCATION OF RECOGNIZED PERIOD COSTS |
The
following table summarizes stock-based compensation recognized for fiscal years 2021 and 2020.
SCHEDULE OF SHARE-BASED COMPENSATION, ALLOCATION OF RECOGNIZED PERIOD COSTS
|
|
2021 |
|
|
2020 |
|
|
|
Year
Ended |
|
|
|
2021 |
|
|
2020 |
|
Employee Stock Options |
|
$ |
178,000 |
|
|
$ |
132,000 |
|
Director Stock Options |
|
|
72,000 |
|
|
|
104,000 |
|
Total |
|
$ |
250,000 |
|
|
$ |
236,000 |
|
|
SCHEDULE OF STOCK OPTIONS ROLL FORWARD |
The
summary of the Company’s total plans as of December 31, 2021 and 2020, and changes during the period then ended are presented as
follows:
SCHEDULE OF STOCK OPTIONS ROLL FORWARD
|
|
Shares |
|
|
Weighted
Average Exercise Price |
|
|
Weighted
Average Remaining Contractual Term (years) |
|
|
Aggregate
Intrinsic
Value
(4)
|
|
Options outstanding January 1, 2021 |
|
|
658,400 |
|
|
$ |
3.87 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
381,000 |
|
|
$ |
6.82 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(500 |
) |
|
$ |
3.15 |
|
|
|
|
|
|
$ |
2,175 |
|
Forfeited/expired |
|
|
(19,500 |
) |
|
$ |
6.75 |
|
|
|
|
|
|
|
|
|
Options outstanding end
of period (1) |
|
|
1,019,400 |
|
|
$ |
4.91 |
|
|
|
4.0 |
|
|
$ |
1,669,687 |
|
Options exercisable at
December 31, 2021(1) |
|
|
438,400 |
|
|
$ |
3.95 |
|
|
|
2.7 |
|
|
$ |
1,064,432 |
|
|
|
Shares |
|
|
Weighted
Average Exercise Price |
|
|
Weighted
Average Remaining Contractual Term (years) |
|
|
Aggregate
Intrinsic
Value
(4)
|
|
Options outstanding January
1, 2020 |
|
|
681,300 |
|
|
$ |
3.84 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
24,000 |
|
|
$ |
6.92 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(12,500 |
) |
|
$ |
3.47 |
|
|
|
|
|
|
$ |
16,060 |
|
Forfeited/expired |
|
|
(34,400 |
) |
|
$ |
5.52 |
|
|
|
|
|
|
|
|
|
Options
outstanding end of period (2) |
|
|
658,400 |
|
|
$ |
3.87 |
|
|
|
3.5 |
|
|
$ |
1,426,143 |
|
Options
exercisable at December 31, 2020(3) |
|
|
356,400 |
|
|
$ |
3.99 |
|
|
|
3.3 |
|
|
$ |
732,163 |
|
(1) |
Options with exercise prices ranging from $2.79 to $7.50 |
(2) |
Options with exercise prices ranging from $2.79 to $7.29 |
(3) |
Options with exercise prices ranging from $2.79 to $7.05 |
(4) |
The intrinsic value of a stock option is the amount by which
the market value of the underlying stock exceeds the exercise price |
|
SCHEDULE OF NON VESTED OPTIONS |
The
summary of the Company’s nonvested options as of December 31, 2021 and changes during the period then ended are presented as follows:
SCHEDULE OF NON VESTED OPTIONS
|
|
|
|
|
Weighted Average |
|
|
|
|
|
|
Grant-Date |
|
|
|
Shares |
|
|
Fair
Value |
|
Non-vested options January 1, 2021 |
|
|
302,000 |
|
|
$ |
1.94 |
|
Granted |
|
|
381,000 |
|
|
|
3.59 |
|
Vested |
|
|
(100,500 |
) |
|
|
2.44 |
|
Forfeited |
|
|
(1,500 |
) |
|
|
1.42 |
|
Non-vested options at December 31, 2021 |
|
|
581,000 |
|
|
$ |
3.13 |
|
|